Nov 21 (Reuters) - The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' (ALNY.O), opens new tab heart disease drug, ensuring access for patients through the government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results